Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Nov 30, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Aug 31, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 89.67%-202.55K | 30.43%-1.96M | 121.05%310.34K | 0.08%-1.23M | -300.10%-997.01K | -134.31%-46.06K | 19.88%-2.82M | -12.95%-1.47M | -41.96%-1.23M | 68.80%-249.19K |
| Net income from continuing operations | -35.29%-823.85K | 77.17%-608.93K | -36.76%-904.6K | 45.09%-427.44K | -45.50%-698.34K | 290.04%1.42M | 46.37%-2.67M | 61.39%-661.45K | 12.32%-778.4K | 55.80%-479.97K |
| Operating gains losses | ---- | -268.25%-1.08M | -287.13%-1.06M | --0 | --0 | -209.62%-25.13K | ---294.03K | ---273.2K | ---20.09K | ---23.67K |
| Asset impairment expenditure | --0 | --209.7K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | --0 | --268.59K | --208.8K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other non cashItems | --11.51K | ---- | ---- | 77.01%-177.34K | 48.04%395.34K | -393.19%-1.53M | -94.41%17.19K | --0 | ---771.34K | 121.01%267.05K |
| Change In working capital | 181.50%609.79K | -697.27%-748.16K | 253.80%543.13K | -546.40%-683.86K | -5,407.60%-694.01K | -74.37%86.58K | 3,336.60%125.26K | -1,049.26%-353.14K | 520.01%153.19K | 79.10%-12.6K |
| -Change in receivables | -70.53%960 | 192.40%3.26K | 131.38%16.22K | 83.38%10.08K | -493.67%-27.86K | -89.82%4.82K | -34.03%-3.53K | -5,716.41%-51.67K | 238.06%5.5K | -192.24%-4.69K |
| -Change in prepaid assets | 220.24%183.87K | -227.11%-152.93K | 574.77%94.79K | 909.58%262.56K | -241,818.78%-514.86K | -94.27%4.58K | 203.59%120.31K | 178.52%14.05K | 123.29%26.01K | -94.08%213 |
| -Change in payables and accrued expense | 171.00%424.95K | -7,158.56%-598.5K | 236.96%432.13K | -886.03%-956.51K | -1,762.96%-151.29K | -63.32%77.18K | -93.07%8.48K | -682.42%-315.52K | 53.70%121.69K | 86.83%-8.12K |
| Cash from discontinued investing activities | 0 | -131.78%-764.44K | 0 | -147.11%-541.08K | -255.97%-250.02K | 106.69%26.66K | 2,983.35%2.41M | 981.41%1.5M | 1,212.08%1.15M | 160.3K |
| Operating cash flow | 92.57%-202.55K | -558.42%-2.73M | 8,853.92%310.34K | -2,658.61%-1.77M | -1,302.88%-1.25M | 92.66%-19.4K | 87.97%-414.02K | 100.30%3.47K | 93.38%-64.16K | 88.24%-88.89K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -209.7K | -38.61K | -86.17K | -84.93K | 0 | 0 | 0 | 0 | |
| Net other investing changes | ---- | ---209.7K | ---38.61K | ---86.17K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | 0 | 995.14K | -2,644.26%-315.81K | 11,291.65%1.31M | 0 | 97.07%-11.51K | 115.40%11.51K | 46K | ||
| Investing cash flow | --0 | --785.44K | -2,979.73%-354.42K | 10,542.88%1.22M | -284.61%-84.93K | --0 | --0 | 97.07%-11.51K | 115.40%11.51K | 169.77%46K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -91.65%164.2K | 1,772.38%1.97M | -3,780.29%-169K | 605.29%708.17K | 1.42M | 10K | -97.62%105K | -94.75%4.59K | -95.51%100.41K | 0 |
| Net issuance payments of debt | 307.79%164.2K | -175.26%-79.02K | --0 | --0 | ---89.02K | --10K | --105K | --4.59K | --100.41K | --0 |
| Net common stock issuance | --0 | --2.28M | ---169K | --763.42K | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---233.4K | --1 | ---55.25K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 0 | 61.70%-34.7K | 89.26%-6.29K | 50.51%-4.1K | -12.73K |
| Financing cash flow | -91.65%164.2K | 2,696.62%1.97M | -9,870.44%-169K | 635.32%708.17K | 11,232.48%1.42M | 186.31%10K | -98.38%70.3K | -105.85%-1.7K | -95.67%96.31K | 81.90%-12.73K |
| Net cash flow | ||||||||||
| Beginning cash position | 193.71%38.56K | -96.50%13.13K | 512.85%251.63K | 1,962.41%88.6K | -93.74%3.73K | -96.50%13.13K | 1,417.61%375.05K | -97.80%41.06K | -99.39%4.3K | -96.25%59.63K |
| Current changes in cash | -250.85%-38.36K | 107.40%25.43K | -2,088.26%-213.07K | 273.44%163.03K | 252.61%84.87K | 97.08%-9.4K | -210.17%-343.73K | 99.36%-9.74K | -96.31%43.66K | 93.77%-55.61K |
| Effect of exchange rate changes | ---- | --0 | --0 | --0 | --0 | --0 | -147.46%-18.19K | -147.46%-18.19K | 66.95%-6.89K | -97.07%281 |
| End cash Position | -99.49%198 | 193.71%38.56K | 193.71%38.56K | 512.85%251.63K | 1,962.41%88.6K | -93.74%3.73K | -96.50%13.13K | -96.50%13.13K | -97.80%41.06K | -99.39%4.3K |
| Free cash from | 92.57%-202.55K | -558.42%-2.73M | 8,853.92%310.34K | -2,658.61%-1.77M | -1,302.88%-1.25M | 92.66%-19.4K | 87.97%-414.02K | 100.30%3.47K | 93.38%-64.16K | 87.58%-88.89K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.